ICL Ebitda from 2010 to 2024

ICL Stock  USD 4.71  0.05  1.07%   
ICL Israel EBITDA yearly trend continues to be quite stable with very little volatility. The value of EBITDA is projected to decrease to about 1.4 B. From the period between 2010 and 2024, ICL Israel, EBITDA regression line of its data series had standard deviation of  954,175,671 and standard deviation of  954,175,671. View All Fundamentals
 
EBITDA  
First Reported
2001-09-30
Previous Quarter
383 M
Current Value
349.5 M
Quarterly Volatility
261.8 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ICL Israel financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ICL main balance sheet or income statement drivers, such as Depreciation And Amortization of 371.6 M, Interest Expense of 120.4 M or Selling General Administrative of 379.1 M, as well as many exotic indicators such as Price To Sales Ratio of 0.8, Dividend Yield of 0.0385 or PTB Ratio of 1.07. ICL financial statements analysis is a perfect complement when working with ICL Israel Valuation or Volatility modules.
  
This module can also supplement ICL Israel's financial leverage analysis and stock options assessment as well as various ICL Israel Technical models . Check out the analysis of ICL Israel Correlation against competitors.

Latest ICL Israel's Ebitda Growth Pattern

Below is the plot of the Ebitda of ICL Israel Chemicals over the last few years. It is ICL Israel's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ICL Israel's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

ICL Ebitda Regression Statistics

Arithmetic Mean1,517,286,599
Geometric Mean1,072,962,240
Coefficient Of Variation62.89
Mean Deviation629,232,205
Median1,441,162,854
Standard Deviation954,175,671
Sample Variance910451.2T
Range4.2B
R-Value0.35
Mean Square Error861206.9T
R-Squared0.12
Significance0.20
Slope74,417,449
Total Sum of Squares12746317T

ICL Ebitda History

20241.4 B
20231.8 B
20224.2 B
20211.8 B
2020757 M
20191.3 B
20181.9 B

About ICL Israel Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include ICL Israel income statement, its balance sheet, and the statement of cash flows. ICL Israel investors use historical funamental indicators, such as ICL Israel's Ebitda, to determine how well the company is positioned to perform in the future. Although ICL Israel investors may use each financial statement separately, they are all related. The changes in ICL Israel's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ICL Israel's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on ICL Israel Financial Statements. Understanding these patterns can help to make the right decision on long term investment in ICL Israel. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA1.8 B1.4 B
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ICL Israel in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ICL Israel's short interest history, or implied volatility extrapolated from ICL Israel options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether ICL Israel Chemicals is a strong investment it is important to analyze ICL Israel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ICL Israel's future performance. For an informed investment choice regarding ICL Stock, refer to the following important reports:
Check out the analysis of ICL Israel Correlation against competitors.
Note that the ICL Israel Chemicals information on this page should be used as a complementary analysis to other ICL Israel's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for ICL Stock analysis

When running ICL Israel's price analysis, check to measure ICL Israel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICL Israel is operating at the current time. Most of ICL Israel's value examination focuses on studying past and present price action to predict the probability of ICL Israel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICL Israel's price. Additionally, you may evaluate how the addition of ICL Israel to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Is ICL Israel's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICL Israel. If investors know ICL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICL Israel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.80)
Dividend Share
0.277
Earnings Share
0.5
Revenue Per Share
5.845
Quarterly Revenue Growth
(0.19)
The market value of ICL Israel Chemicals is measured differently than its book value, which is the value of ICL that is recorded on the company's balance sheet. Investors also form their own opinion of ICL Israel's value that differs from its market value or its book value, called intrinsic value, which is ICL Israel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICL Israel's market value can be influenced by many factors that don't directly affect ICL Israel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICL Israel's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICL Israel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICL Israel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.